Grifols (GRFS) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

GRFS Grifols

Watchlist

7.130
+0.140+2.00%

Close Dec 2 16:00 ET

7.080
-0.050-0.70%

Post 18:02 ET

4.85BMarket Cap28.29P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

'Grifols Shareholder Mason Capital Calls For Board Overhaul' - Bloomberg News
Benzinga15:29 ET
Key Deals This Week: EnLink Midstream, Peabody, StoneCo, UniCredit and More
Seeking AlphaNov 30 13:45 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
BenzingaNov 29 16:06 ET
Slow Market Manages Closing Records for S&P 500 and Dow | Wall Street Today
Kevin TraversNov 29 13:13 ET
US Equities Markets End Higher in Shortened Session After Thanksgiving Holiday
MT NewswiresNov 29 13:02 ET
Sector Update: Health Care Stocks Rise in Afternoon Trading
MT NewswiresNov 29 12:49 ET

Comments

Trytosaveabit

Oct 29 07:12

News

$Grifols (GRFS.US)$ Grifols Receives FDA Approval To Treat Surgical Bleeding In Pediatric Patients With Its Fibrin Sealant Solution
Benzinga· 3 mins ago

Trytosaveabit

Oct 3 07:12

If any seen that for the 40 seconds it was posted!

$Grifols (GRFS.US)$ I removed the post because i think the PR was tagged to the wrong ticker by the NEWS OUTLETT! And i want to be more safe and check a bit more!

Trytosaveabit

Aug 21 03:57

A bit added to older PR ( seeking backing ) is the new!

$Grifols (GRFS.US)$ Investing.com -- Shares of Grifols SA (BME:GRLS) (NASDAQ:GRFS) rose on Wednesday after Bloomberg News reported that Brookfield Asset Management (TSX:BAM) is seeking bank backing for up to €9.5 billion in debt to facilitate its potential take-private acquisition of the Spanish pharmaceutical producer

Trytosaveabit

Jul 29 07:04

News

$Grifols (GRFS.US)$ Benzinga· 2 mins ago
FDA Approves Expanded Label For Grifols' XEMBIFY, The First 20% SCIg For Treatment-Naïve Patients With Primary Humoral Immunodeficiencies; Approval Includes Biweekly Dosing Following Positive Phase 4 Data, Enhancing Flexibility And Convenience For Patients

Kevin Travers

Jul 8 09:50

Columns Fresh Highs Before Flat Trading, Last Week Before Q2 Earnings | Herd on Wall Street

Morning traders, it is the final slow week before a new earnings season begins Thurday with $Delta Air Lines (DAL.US)$ and properly on Friday with $JPMorgan (JPM.US)$.
Welcome to the end of the dog days of summer for a while; my name is Kevin Travers, and here are stories from the moomoo herd on Wall Street today.
$Intel (INTC.US)$ traded higher after the firm said it had bypassed Vietnam for a $3.3B project and in...

Live Stock Financial Podcast. What are you watching on the market?

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

GRFS Grifols

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target